Clinical Trial

Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT

Name: Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT — clinical trial record (NCT06963866)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASCTvsCAR-T

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a prospective study comparing autologous hematopoietic stem cell transplantation followed by anti-BCMA CAR-T to autologous hematopoietic stem cell transplantation alone in the treatment of newly diagnosed multiple myeloma patients.

Trial Details

NCT Number	NCT06963866
Lead Sponsor	Xuzhou Medical University
Conditions	Multiple Myeloma, Newly Diagnosed
Enrollment	60 participants
Start Date	2025-05-01
Primary Completion	2028-04-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-09